Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07066085 · ClinicalTrials.gov registry record · Early Phase 1
Serial Blood Count Study
A Early Phase 1 study of Neutropenia and Congenital Neutropenia, sponsored by University of Washington.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07066085 is a Early Phase 1 study of Neutropenia and Congenital Neutropenia that is actively recruiting participants, run by University of Washington. The registered enrollment target is 20 participants, below the 76-participant average among 12 other Neutropenia trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07066085, a Early Phase 1 study of Neutropenia and Congenital Neutropenia, is actively recruiting participants, sponsored by University of Washington.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to diagnose cyclic neutropenia and distinguish between cyclic and severe congenital neutropenia (SCN). A new home monitoring device called Athelas One was granted an FDA 510K Class 2 clearance for evaluation of white blood count (WBC) and absolute neutrophil count (ANC). The investigators believe this device provides a unique and extremely valuable opportunity to for diagnosis of these diseases.
Conditions Studied
Interventions
- DEVICE Serial Blood Count Study
- DEVICE Athelas Home device
Study Locations (1)
Washington
- University of Washington Medical Center - Montlake - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2024-10-17 |
| Est. Completion | 2025-12-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07066085
The ClinicalTrials.gov registry entry for NCT07066085 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 76-participant average among 12 other Neutropenia trials with a reported enrollment target (74% lower). The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Neutropenia appearing as the primary indexed condition, and to 2 interventions - of which Serial Blood Count Study is the first listed.
NCT07066085 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT07066085 about?
NCT07066085 is a clinical study titled "Serial Blood Count Study". The objective of the Serial Blood Count Study is to determine the utility of home monitoring of white blood cell (WBC) and absolute neutrophil counts (ANC) to diagnose cyclic neutropenia and distinguish between cyclic and severe congenital neutropenia (SCN). A new home monitoring device called Athel...
What is the current status of trial NCT07066085?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 20 participants. The study started on 2024-10-17. Estimated completion is 2025-12-01.
What conditions does trial NCT07066085 study?
This clinical trial studies the following conditions: Neutropenia, Congenital Neutropenia, Cyclic Neutropenia.
What interventions are being tested in trial NCT07066085?
The interventions under investigation include: Serial Blood Count Study (DEVICE), Athelas Home device (DEVICE).
Who is sponsoring clinical trial NCT07066085?
This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07066085 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Neutropenia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia
RECRUITING · Phase 2
-
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
RECRUITING · Phase 1
-
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
RECRUITING · Phase 4
-
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
RECRUITING · Phase 3
-
Luspatercept for Clonal Cytopenias of Uncertain Significance
RECRUITING · Phase 2
-
Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.